What ethical and legal principles should guide the genotyping of children as part of a personalised screening programme for common cancer?

Journal of Medical Ethics

Volumn 40, Issue 3, 2014, Pages 163-167

  Hall, Alison Elizabeth ^a   Chowdhury, Susmita ^a   Pashayan, Nora ^b   Hallowell, Nina ^a   Pharoah, Paul ^c,d   Burton, Hilary ^a  

^a PHG FOUNDATION   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUTONOMY; ETHICS; EUROPE; FEMALE; GENETHICS; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETIC SCREENING/TESTING; GENETICS; GENOTYPE; HUMAN; INFANT; LEGAL ASPECT; MALE; MASS SCREENING; MORALITY; NEOPLASM; NEWBORNS AND MINORS; PARENTAL CONSENT; PERSONALIZED MEDICINE; PREDICTIVE VALUE; PRESCHOOL CHILD; PUBLIC HEALTH ETHICS; RISK ASSESSMENT; RISK FACTOR;

AUTONOMY; GENETHICS; GENETIC SCREENING/TESTING; NEWBORNS AND MINORS; PUBLIC HEALTH ETHICS;

ADULT; CHILD, PRESCHOOL; EUROPE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOTYPE; HUMANS; INDIVIDUALIZED MEDICINE; INFANT; MALE; MASS SCREENING; MORALS; NEOPLASMS; PARENTAL CONSENT; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS;

EID: 84894241639     PISSN: 03066800     EISSN: 14734257     Source Type: Journal    
DOI: 10.1136/medethics-2012-101079     Document Type: Article

References (53)

1. Human Genetics Commission. Profiling the newborn: a prospective gene technology? http://www.hgc.gov.uk 2005.
2. Pashayan N, Duffy SW, Chowdhury S, et al. Polygenic susceptibility to prostate and breast cancer; implications for personalised screening. Br J Cancer 2011; 104(10):1-8.
3. Becker F, van El CG, Ibarreta D, et al. Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Eur J Hum Genet 2011;19:S6-S44.
4. Howell A, Astley S, Warwick J, et al. Prevention of breast cancer in the context of a national breast screening programme. J Intern Med 2012;271:321-30.
5. Elmore JG, Fletcher SW. Overdiagnosis in breast cancer screening: time to tackle an underappreciated harm. Ann Intern Med 2012;156:536-7.
6. British Society of Human Genetics. Genetic testing of children: report of a working party of the British Society of Human Genetics. Br Soc Hum Genet 2010.
7. Mand C, Gillam L, Delatycki MB, et al. Predictive genetic testing in minors for late-onset conditions: a chronological and analytical review of the ethical arguments. J Med Ethics 2012;38(9):519-24.
8. Clarke A. Commentary on predictive genetic testing of minors: by Mand et al. J Med Ethics 2012;38(9):527-8.
9. Nicholls SG. Proceduralisation, choice and parental reflections on decisions to accept newborn bloodspot screening. J Med Ethics 2011;38(5):299-303.
10. Kerruish NJ, Robertson SP. Newborn screening: new developments, new dilemmas. J Med Ethics 2005;31:393-8.
11. Tercyak KP, Hensley Alfond S, Emmons KM, et al. Parents' attitudes towards pediatric genetic testing for common disease risk. Pediatrics 2011;127(5): 1288-95.
12. Tercyak KP, Streisand R, Peshkin B, et al. Psychosocial impact of predictive testing for illness on children and families: challenges for a new millenium. J Clin Psychol Med Settings 2000;7(1):55-68.
13. McConkie-Rosell A, Spiridigliozzi GA, Sullivan JA, et al. Carrier testing in fragile X syndrome: when to tell and test. Am J Med Genet 2002;110:36-44.
14. Wade CH, Shiloh S, Woolford SW, et al. Modeling decisions to undergo genetic testing for susceptibility to common health conditions: an ancilliary study of the multiplex initiative. Psychol Health 2012;27(4):430-44.
15. Public and Professional Policy Commitee ESHG. Genetic testing in asymptomatic minors: recommendations of the European Society of Human Genetics. Eur J Hum Genet 2009;17:720-1.
16. Senior V, Marteau TM, Peters TJ. Will genetic testing for predisposition for disease result in fatalism? A qualitative study of parents responses to neonatal screening for familial hypercholesterolaemia. Soc Sci Med 1999;48:1857-60.
17. Biesecker LG. Opportunities and challenges for the integration of massively parrallel genomic sequencing into clinical practice: lessons from the Clinseq project. Genet Med 2012;14(4):393-8.
18. McGuire AL, Diaz CM, Wang T, et al. Social networkers' attitudes toward direct-to-consumer personal genome testing. Am J Bioeth 2009;9(6-7):3-10.
19. Bloss CS, Schork NJ, Topol EJ. Effect of direct-to-consumer genomewide profiling to assess disease risk. N Engl J Med 2011;364(6):524-34.
20. Duncan R, Deltycki MB. Predictive genetic testing in young people for adult-onset conditions: where is the empirical evidence? Clin Genet 2006;69:8-16.
21. Marteau TM, Lerman C. Genetic risk and behavioural change. BMJ 2001;322:1056-9.
22. Marteau TM, French DP, Griffin SJ, et al. Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours (Review). Cochrane Database Syst Rev 2010;2010(10):Art No. CD007275.
23. Tercyak KP, Peshkin BN, Streisand R, et al. Psychological issues among children of hereditary breast cancer gene (BRCA1/2) testing participants. Psychooncology 2001;10:336-46.
24. Lewis S, Curnow L, Ross M, et al. Parental attitudes to the identification of their infants as carriers of cystic fibrosis by newborn screening. J Paediatr Child Health 2006;42:533-7.
25. Asscher E, Koops BJ. The right not to know and preimplantation genetic diagnosis for Huntington's disease. J Med Ethics 2010;36:30-3.
26. Boyce A, Borry P. Parental authority, future autonomy, and assessing risks of predictive genetic testing in minors. Bioethical Inquiry 2009;6:379-85.
27. Umans-Eckenhausen MA, Oort FJ, Ferenschild KC, et al. Parental attitude towards genetic testing for familial hypercholesterolaemia in children. J Med Genet 2002;39(e49):1-4.
28. Rubinstein WS, Acheson LS, O'Neill SM, et al. Clinical utility of family history for cancer screening and referral in primary care: a report from the family healthware impact trial. Genet Med 2012;13(11):956-65.
29. McGuire AL, Oliver JM, Slashinski MJ, et al. To share or not to share: a randomized trial of consent for data sharing in genome research. Genet Med 2011;13(11):948-55.
30. Caulfield T. Know your genes. The marketing of direct-to-consumer genetic testing. Predictive or preposterous? The marketing of DTC genetic testing. J Sci Commun 2011;10(3):1-5.
31. Hedgecoe A. Geneticization, medicalisation and polemics. Med Health Care Philos 1998;1:235-43.
32. Árnason V, Hjörleifsson S. Geneticization and bioethics: advancing debate and research. Med Health Care Philos 2007;10:417-31.
33. Stultiëns L, Goffin T, Borry P, et al. Minors and informed consent: a comparative approach. Eur J Health Law 2007;14:21-46.
34. Borry P, Fryns JP, Schotsmans P, et al. Carrier testing in minors: a systematic review of guidelines and position papers. Eur J Hum Genet 2006;14:133-8.
35. Borry P, Stultiens L, Goffin T, et al. Minors and informed consent in carrier testing: a survey of European clinical geneticists. J Med Ethics 2008;34:370-4.
36. Hens K, Nys H, Cassiman JJ, et al. Biological sample collections from minors for genetic research: a systematic review of guidelines and position papers. Eur J Hum Genet 2009;17:979-90.
37. Borry P, Stultiëns L, Nys N, et al. Presymptomatic and predictive genetic testing in minors: a systematic review of guidelines and position papers. Clin Genet 2006;70:374-81.
38. Clinical Genetics Society. Genetic testing of children: Report of a working party of the clinical genetics society. Br Soc Hum Genet 1994.
39. Borry P, Evers-Kiebooms G, Cornel MC, et al. Genetic testing in asymptomatic minors. Background considerations towards the ESHG Recommendations. Eur J Hum Genet 2009;17:711-19.
40. Children Act. Chapter 41 UK Parliament The Stationery Office 1989.
41. High Court of Justice Family Division. An NHS Trust v MB (A child represented by the Children and Family Court Advisory & Support Service as guardian ad litem), Mr & Mrs B (parents). [2006] EWHC 507 (Fam) 2006.
42. Galiatsatos P, Foulkes WD. Familial adenomatous polyposis. Am J of Gastroenterol 2006;101:385-98.
43. Council of Europe. Convention for the protection of human rights and dignity of the human being with regard to the application of biology and medicine. Oviedo: Council of Europe, 1997.
44. McConkie-Rosell A, Spiridigliozzi GA. 'Family matters': a conceptual framework for genetic testing in children. J Genet Couns 2004;13(1):9-29.
45. Wilson JM, Jungner YG. Principles and practice of screening for disease. Geneva: WHO, 1968.
46. Kerruish NJ. Parents' experiences of newborn screening for genetic susceptibility to type 1 diabetes. J Med Ethics 2011;37:348-53.
47. Andermann A, Blancquaert I, Beauchamp S, et al. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. Bull World Health Organisation 2008;86(4):240-320.
48. Khoury MJ, McCabe LL, McCabe ER. Population screening in the age of genomic medicine. N Engl J Med 2003;348(50):58.
49. PHG Foundation. Next steps in the sequence: the implications of whole genome sequencing for health in the UK. Cambridge, UK: PHG Foundation, 2011.
50. Zuk O, Hechter E, Sunyaev SR, et al. The mystery of missing heritability: genetic interactions create phantom heritability. Proc Natl Acad Sci 2012;109:1193-8.
51. Goldenberg AJ, Sharp RR. The ethical hazards and programmatic challenges of genomic newborn screening. JAMA 2012;307(5):461-2.
52. Dondorp WJ, de Wert GM, Niermeijer MF. Genomic sequencing in newborn screening programs. JAMA 2012;307(20):2146.
53. Greely SA, Msali M, Acharya K. Genomic sequencing in newborn screening programs. JAMA 2012;307(20):2146-7.